MTL Cannabis Corp. cultivates and produces cannabis products for recreational and medical use in Canada. The company shows strengths in its gross margin of 44.7%, indicating efficient production, but faces significant concerns with negative EBITDA and net margins of -25.3% and -40.4%, respectively, reflecting ongoing financial challenges. Additionally, a high debt-to-equity ratio of 2.16 raises leverage concerns, while a current ratio of 1.64 suggests adequate liquidity. Overall, despite solid margins, the company's financial health is weak, warranting caution for potential investors.
Loading financial metrics...
Debt of $48.3M is 16.4x the company's cash position of $3.0M.
Company went from $1.3M profit to $-5.0M loss compared to last year.
Exceptional revenue growth of 35.8% YoY demonstrates strong market demand and competitive positioning.
Strong gross margin of 50.7% reflects healthy unit economics.
Valuation, risk assessment, competitive positioning, and key insights — all in one report.
Other Tobacco companies of a similar size
Based on 2026-Q2 (September 30, 2025)